P1–082PATTERNS OF EFFICACY, TOXICITY AND TREATMENT DISCONTINUATION IN HCC PATIENTS RECEIVING CAPECITABINE MONOTHERAPY.

MLA

Abdel-Rahman, O. M., et al. “P1–082Patterns of Efficacy, Toxicity and Treatment Discontinuation in Hcc Patients Receiving Capecitabine Monotherapy.” Annals of Oncology, vol. 24, Nov. 2013, p. ix72. EBSCOhost, https://doi.org/10.1093/annonc/mdt460.29.

APA

Abdel-Rahman, O. M., Abdelwahab, M. M., Shaker, M. K., Abdelwahab, S. A., Elbassiony, M. M., & Ellithy, M. M. (2013). P1–082Patterns of Efficacy, Toxicity and Treatment Discontinuation in Hcc Patients Receiving Capecitabine Monotherapy. Annals of Oncology, 24, ix72. https://doi.org/10.1093/annonc/mdt460.29

Chicago

Abdel-Rahman, O. M., M. M. Abdelwahab, M. K. Shaker, S. A. Abdelwahab, M. M. Elbassiony, and M. M. Ellithy. 2013. “P1–082Patterns of Efficacy, Toxicity and Treatment Discontinuation in Hcc Patients Receiving Capecitabine Monotherapy.” Annals of Oncology 24 (November): ix72. doi:10.1093/annonc/mdt460.29.